Lansoprazole Capsule, Delayed Release
Product Images NDC 63629-2340

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 63629-2340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

This is a chart that shows the mean severity of day heartburn by study day for evaluable patients. The severity is measured on a scale of 0 (none) to 3 (severe). The chart includes data for a placebo group and two groups taking different doses of lansoprazole. The chart is broken down by the number of days from the start of treatment.*

FDA Label Image

Figure-2.jpg (Figure 2)

The text represents a table that shows the Mean Severity of Night Heartburn for different treatment groups (Placebo, Lansoprazole 15mg QD, and Lansoprazole 30mg QD) on different study days. The severity is measured on a scale of 0 to 3, where 0 means no heartburn and 3 means severe heartburn. The table also shows the percentage of patients who experienced heartburn on each study day.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label (Lbl636292340)

This text is a product label for Lansoprazole Delayed-Release Capsules, 30 mg manufactured by BRP Pharmaceuticals. It also contains instructions for storage and dispensing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.